Chronic inflammation often develops gradually and over a long period of time, often as a result of an incorrect or overreaction of the body.
In our industrialized society, they have become an epidemic of modern life.
Acute inflammation can become chronic, and chronic inflammation often has acute flare-ups.
A healthy immune reaction is described as pathologically chronic when it becomes a permanently stressful condition.
INUSpheresis® is based on the principle of DFPP, an immune filtering process that removes pro-inflammatory substances from the blood.
This therapy can relieve the body and bring the immune system back into balance.
It calms the immune system and promotes the regeneration of the body.
It also supports the body’s own healing mechanisms and helps to alleviate chronic inflammatory processes.
INUSpheresis® is a gentle form of therapy that is carried out on an outpatient basis and individually adapted.
Patients generally experience an improvement in symptoms, an increase in quality of life and a general sense of well-being.
INUSpheresis® therapy can effectively and positively influence chronic inflammation.
INUSpheresis® is an effective supplement to symptomatic therapy and shows promising results in the treatment of chronic inflammation.
It can be used in acute phases as well as for prevention and long-term treatment.
In addition to INUSpheresis®, the personal living environment should be freed from pollutants as far as possible.
This includes avoiding harmful substances in food, cosmetic products and in the home.
In summary, it can be said that chronic inflammation is a serious health challenge that can have a significant impact on the well-being and quality of life of those affected.
However, holistic treatment, which includes both symptomatic and preventive measures, can help to reduce the burden of chronic inflammation and improve quality of life.
Lyme disease, a bacterial infectious disease that can be transmitted to humans not only by ticks but also by other insects such as horseflies, mosquitoes, flies, fleas, etc., is likely to be indirectly responsible for the neurological symptoms of long COVID, post-COVID, post-vaccine and chronic fatigue syndrome.
The “dormant” borrelia are reactivated by COVID spike proteins through the weakening of the immune system (perhaps also directly, note: under investigation).
Borrelia are rather difficult for conventional antibiotics to access in order to be combated efficiently in the long term.
In natural medicine, annual mugwort and wild teasel are very effective.
INUSpheresis, which we carry out at Lissi Med Wiener Neustadt, filters the majority of borrelia and associated infectious agents such as toxoplasma, clamydia, EBV, CMV etc. from the blood with excellent results.
The above-mentioned natural remedies do the rest.
The “last resort” would be hyperthermia in sedoanalgesia at 41.5 degrees Celsius, which is also offered at Lissi Med and can kill the last stubborn remnants of Borrelia.
We always follow our D – T – A concept. Before we draw up a treatment plan together with our patients, it is important to make a diagnosis in advance based on the patient’s medical history. After approx. 7 to 10 days, the laboratory results provide a picture on which the treatment plan can be based.
As a rule, two INUSpheresis® treatments are initially carried out within 72 hours. After the 2nd INUSpheresis®, therapy is continued with further infusions or molecular medication as required. The determination of the genetic degree of inflammation, which is measured in the “genetic cytokine polymorphism”, is also useful in this context. Patients with a genetically increased degree of inflammation generally require more apheresis for successful treatment than patients with a genetically low degree of inflammation. Due to the outstanding importance of the pro-inflammatory key cytokines TNF-α and IL-1 as well as their counterpart IL-1RN for the individual inflammatory tendency, it has become established to grade the inflammatory tendency based on the respective genetic constellations of a patient.
Patients with an inflammation grade of 0 and 1 are referred to as low-responders, as they have a normal inflammatory capacity. In grade 3 and 4 patients, so-called high-responders, on the other hand, there is a genetically determined strong increase in inflammation. Studies have shown the importance of the IL-1 or TNF-α genotype in a number of systemic inflammatory diseases, such as diabetes, multiple sclerosis, chronic bronchitis, asthma, chronic inflammatory bowel disease, periostitis, osteomyelitis or osteoporosis.
Our aim is to restore the function and communication of your cells and your immune system to a normal state.
Follow us on social media to be informed about current service news!